CA2987798A1 - Compositions and methods for treating inflammatory disease or conditions - Google Patents

Compositions and methods for treating inflammatory disease or conditions

Info

Publication number
CA2987798A1
CA2987798A1 CA2987798A CA2987798A CA2987798A1 CA 2987798 A1 CA2987798 A1 CA 2987798A1 CA 2987798 A CA2987798 A CA 2987798A CA 2987798 A CA2987798 A CA 2987798A CA 2987798 A1 CA2987798 A1 CA 2987798A1
Authority
CA
Canada
Prior art keywords
nsaid
cochleate
less
subject
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2987798A
Other languages
English (en)
French (fr)
Inventor
Raphael J. Mannino
Ruying Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matinas Biopharma Nanotechnologies Inc
Original Assignee
Matinas Biopharma Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matinas Biopharma Nanotechnologies Inc filed Critical Matinas Biopharma Nanotechnologies Inc
Publication of CA2987798A1 publication Critical patent/CA2987798A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2987798A 2015-06-18 2016-06-17 Compositions and methods for treating inflammatory disease or conditions Abandoned CA2987798A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562181347P 2015-06-18 2015-06-18
US62/181,347 2015-06-18
US201662289025P 2016-01-29 2016-01-29
US62/289,025 2016-01-29
US201662347014P 2016-06-07 2016-06-07
US62/347,014 2016-06-07
PCT/US2016/038084 WO2016205654A1 (en) 2015-06-18 2016-06-17 Compositions and methods for treating inflammatory disease or conditions

Publications (1)

Publication Number Publication Date
CA2987798A1 true CA2987798A1 (en) 2016-12-22

Family

ID=57546667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2987798A Abandoned CA2987798A1 (en) 2015-06-18 2016-06-17 Compositions and methods for treating inflammatory disease or conditions

Country Status (8)

Country Link
US (1) US20180185308A1 (enExample)
EP (1) EP3310338A4 (enExample)
JP (1) JP2018517736A (enExample)
KR (1) KR20180014790A (enExample)
CN (1) CN107920991A (enExample)
AU (1) AU2016280276A1 (enExample)
CA (1) CA2987798A1 (enExample)
WO (1) WO2016205654A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180004104A (ko) 2015-03-03 2018-01-10 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 코클레이트 및 약리학적 활성제의 조직 침투를 향상시키기 위해 이를 사용하는 방법
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759057B1 (en) * 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
WO2001052817A2 (en) * 2000-01-24 2001-07-26 Biodelivery Sciences, Inc. Cochleate formulations and their use for delivering biologically relevant molecules
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
CA2504329C (en) * 2002-11-01 2013-08-20 Biodelivery Sciences International, Inc. Geodate delivery vehicles
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP6347743B2 (ja) * 2011-05-05 2018-06-27 マティナス バイオファーマ ナノテクノロジーズ，インコーポレーテッド コクリエート組成物およびその製造および使用方法
MX361155B (es) * 2012-07-30 2018-11-28 Matinas Biopharma Nanotechnologies Inc Cocleatos hechos con fosfatidilserina de soja.

Also Published As

Publication number Publication date
JP2018517736A (ja) 2018-07-05
US20180185308A1 (en) 2018-07-05
AU2016280276A1 (en) 2017-12-07
EP3310338A1 (en) 2018-04-25
CN107920991A (zh) 2018-04-17
EP3310338A4 (en) 2018-12-26
WO2016205654A1 (en) 2016-12-22
KR20180014790A (ko) 2018-02-09

Similar Documents

Publication Publication Date Title
CN103260702B (zh) 非甾体类抗炎药的缓释制剂
ES2867152T3 (es) Composiciones y métodos para el tratamiento de infecciones y enfermedad pulmonar por micobacterias
US11679157B2 (en) Controlled release mucoadhesive systems
WO2019023092A1 (en) LIPOSOME COMPOSITIONS COMPRISING LOW ACID BASED MEDICAMENTS AND USES THEREOF
JP7173615B2 (ja) 徐放性麻酔組成物及びその調製方法
CA2978308C (en) Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
CN110693890A (zh) 用于治疗呈现至少一种炎性组分的肠道疾病的方法
CN101557828A (zh) 用于治疗炎性肠病的磷脂与含有5-氨基水杨酸之药物的制备物
US20180185308A1 (en) Compositions and methods for treating inflammatory disease or conditions
EP2231190B1 (en) Particulate drug carriers as desensitizing agents
WO2005041932A2 (en) Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same
CN115175664A (zh) 包含ati受体阻滞剂的脂质体制剂及其用途
JP7186093B2 (ja) 前眼部疾患の治療のためのタクロリムスの持続送達用ナノリポソーム
BR112021000316A2 (pt) Métodos para reduzir complicações de esteroide intra-articular
BR122024008482A2 (pt) Composições anestésicas de liberação sustentada
WO2017115358A1 (en) Liposomes for treatment of an autoimmune disease
HK1188408B (en) A sustained release formulation of a non-steroidal anti-inflammatory drug
HK1188408A (en) A sustained release formulation of a non-steroidal anti-inflammatory drug

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220301